Wells Fargo & Company Oramed Pharmaceuticals Inc. Transaction History

Wells Fargo & Company

$429 Billion
Q1 2025

A detailed history of Wells Fargo & Company transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 20,986 shares of ORMP stock, worth $45,749. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,986

Previous 23,586 11.02%

Holding current value

$45,749

Previous $57,000 22.81%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$2.0 - $2.62 $5,200 - $6,812	-2,600 Reduced 11.02%	20,986 $44,000
Q4 2024 Feb 12, 2025	SELL	$2.17 - $2.52 $3,255 - $3,780	-1,500 Reduced 5.98%	23,586 $57,000
Q3 2024 Nov 13, 2024	SELL	$2.21 - $2.63 $1,105 - $1,315	-500 Reduced 1.95%	25,086 $61,000
Q2 2024 Aug 13, 2024	BUY	$2.07 - $2.83 $37,435 - $51,180	18,085 Added 241.1%	25,586 $65,000
Q1 2024 May 10, 2024	BUY	$2.18 - $3.58 $6,540 - $10,740	3,000 Added 66.65%	7,501 $21,000
Q3 2023 Nov 13, 2023	SELL	$2.51 - $3.55 $3,764 - $5,325	-1,500 Reduced 25.0%	4,501 $11,000
Q2 2023 Aug 15, 2023	BUY	$2.12 - $4.47 $4,030 - $8,497	1,901 Added 46.37%	6,001 $21,000
Q1 2023 May 12, 2023	SELL	$1.93 - $13.1 $116,923 - $793,624	-60,582 Reduced 93.66%	4,100 $8,000
Q4 2022 Feb 13, 2023	BUY	$5.88 - $12.03 $31,458 - $64,360	5,350 Added 9.02%	64,682 $778,000
Q3 2022 Nov 14, 2022	BUY	$4.6 - $9.91 $247,277 - $532,721	53,756 Added 964.06%	59,332 $384,000
Q2 2022 Aug 12, 2022	SELL	$3.72 - $9.0 $459,364 - $1.11 Million	-123,485 Reduced 95.68%	5,576 $26,000
Q1 2022 May 16, 2022	BUY	$8.19 - $13.89 $312,030 - $529,195	38,099 Added 41.88%	129,061 $1.12 Million
Q4 2021 Feb 14, 2022	BUY	$12.98 - $29.75 $1.07 Million - $2.45 Million	82,213 Added 939.68%	90,962 $1.3 Million
Q3 2021 Nov 15, 2021	BUY	$12.13 - $23.82 $42,236 - $82,941	3,482 Added 66.11%	8,749 $192,000
Q2 2021 Aug 16, 2021	BUY	$8.34 - $14.59 $15,987 - $27,969	1,917 Added 57.22%	5,267 $71,000
Q1 2021 May 13, 2021	BUY	$4.22 - $11.33 $2,110 - $5,665	500 Added 17.54%	3,350 $34,000
Q3 2020 Nov 05, 2020	SELL	$2.58 - $4.16 $4,063 - $6,552	-1,575 Reduced 35.59%	2,850 $7,000
Q2 2020 Aug 13, 2020	BUY	$2.87 - $4.12 $1,650 - $2,369	575 Added 14.94%	4,425 $16,000
Q1 2020 May 14, 2020	BUY	$2.6 - $5.5 $10,010 - $21,175	3,850 New	3,850 $12,000

Others Institutions Holding ORMP

# of Institutions

Shares Held

8.21M

Call Options Held

11.2K

Put Options Held

200

View Full List

About ORAMED PHARMACEUTICALS INC.

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $84.6M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

More about ORMP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Oramed Pharmaceuticals Inc. Transaction History